difference between sglt2 and glp 1 Inhibitors GLP-1 Receptor Agonists in Cardiovascular–Kidney–Metabolic Syndrome Use of GLP-1 Receptor Agonists

#glp1 #glp1news #wellness #healthylifestyle The struggle is REAL so here are some tips #wellnessjourney #healthylifestyle #lifestylechange #glp1journey #glp1community #healthyliving#glp1hairloss#hairthinning Save for later Every week looks a little different but I try to stick to this best I can

Zooming out, the obesity market is now clearly split across modalities: Novo Nordisk still anchors the peptide side with semaglutide, while oral small molecules are accelerating (orforglipron, elecoglipron and Roches Carmot deal)

Some of the most compelling evidence for this came when Novo Nordisk began testing a once-weekly version developed by Knudsens team, called semaglutide

Eur J Cancer 170:236255